FAs reduce mTORC1/c-MY signaling in NKs and the rates of glycolysis and OXPHOS, which results in the low production of interferon gamma (IFN-γ), granzyme B and perforin and reduced cytotoxicity to targeted tumor cells [140]. Here, IFNG is linked to neoplasm.